Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Medication Systems (IMS), a subsidiary of Amphastar Pharmaceuticals, is a pharmaceutical manufacturer specializing in sterile injectable products and drug delivery systems. The company is widely recognized for its proprietary Min-I-Jet and Luer-Jet pre-filled syringe systems, which are designed for rapid use in emergency and critical care settings. IMS produces a broad portfolio of essential generic medications, including epinephrine, naloxone, and lidocaine, used by hospitals and emergency responders worldwide. Its manufacturing operations emphasize high-quality aseptic processing and innovative packaging to improve patient safety and clinical efficiency. The company's products are integral to Advanced Cardiac Life Support (ACLS) and other emergency medical protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intl Medication.